Thank you for visiting the Vantage℠ Program enrollment site. We are
pleased to inform you that Vantage and any applicable saving offers
for VESIcare® (solifenacin succinate) tablets have
been transitioned to the new Momentum program. Please click
on the link below to be redirected to the Momentum enrollment
site where you can begin the enrollment process and see full terms
and conditions. Restrictions apply.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.